Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Last 12 months price action with 12-month analyst target path
As of May 6, 2026, Comerica Incorporated (CMA) has a Wall Street consensus price target of $103.00, based on estimates from 62 covering analysts. With the stock currently trading at $88.67, this represents a potential upside of +16.2%. The company has a market capitalization of $11.35B.
Analyst price targets range from a low of $89.00 to a high of $114.00, representing a 24% spread in expectations. The median target of $106.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 15 analysts rating the stock as a Buy or Strong Buy,35 rating it Hold, and 12 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, CMA trades at a trailing P/E of 16.8x and forward P/E of 16.5x. The forward PEG ratio of 1.84 indicates reasonable valuation for growth. Analysts expect EPS to grow -1.2% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $101.72, with bear and bull scenarios of $69.88 and $305.65 respectively. Model confidence stands at 50/100, reflecting moderate uncertainty in projections.
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationSide-by-side business, growth, and profitability comparison vs Berkshire Hathaway Inc..
Start ComparisonQuick answers to the most common questions about buying CMA stock.
Comerica Incorporated (CMA) has a consensus 12-month price target of $103, implying 16.2% upside from $88.67. The 62 analysts covering CMA see moderate appreciation potential.
CMA has a consensus rating of "Hold" based on 62 Wall Street analysts. The rating breakdown is mixed, with 35 Hold ratings making up the largest segment. The consensus 12-month price target of $103 implies 16.2% upside from current levels.
With a forward P/E of 16.51x, CMA trades at a relatively low valuation. The consensus target of $103 implies 16.2% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $114 for CMA, while the most conservative target is $89. The consensus of $103 represents the median expectation. Our quantitative valuation model projects a bull case target of $306 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
CMA is heavily covered by Wall Street, with 62 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 15 have Buy ratings, 35 recommend Hold, and 12 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month CMA stock forecast based on 62 Wall Street analysts shows a consensus price target of $103, with estimates ranging from $89 (bear case) to $114 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $102, with bear/bull scenarios of $70/$306.
Our quantitative valuation model calculates CMA's fair value at $102 (base case), with a bear case of $70 and bull case of $306. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 50/100.
CMA trades at a forward P/E ratio of 16.5x based on next-twelve-months earnings estimates compared to a trailing P/E of 16.8x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are optimistic on CMA, with a "Hold" consensus rating and $103 price target (16.2% upside). 15 of 62 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
CMA analyst price targets range from $89 to $114, a 24% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $103 consensus represents the middle ground. Our model's $70-$306 range provides an independent fundamental perspective.